好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The TIGIT/CD226/CD155 axis is differentially expressed in MS and glioblastoma: implications for autoimmunity and tumor immune escape.
Multiple Sclerosis
(-)
043
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Sharon G. Lynch, MD, FAAN (Univ of Kansas Medical Center) The institution of Dr. Lynch has received research support from National MS society. The institution of Dr. Lynch has received research support from PCORI. The institution of Dr. Lynch has received research support from Novartis. The institution of Dr. Lynch has received research support from Roche. The institution of Dr. Lynch has received research support from Chugai. The institution of Dr. Lynch has received research support from Sanofi. The institution of Dr. Lynch has received research support from Alexion. The institution of Dr. Lynch has received research support from EMD Serono. The institution of Dr. Lynch has received research support from Celgene. The institution of Dr. Lynch has received research support from Atara. The institution of Dr. Lynch has received research support from TG Therapeutics. The institution of Dr. Lynch has received research support from Medimmune. The institution of Dr. Lynch has received research support from Anokion. The institution of Dr. Lynch has received research support from Adamas. Dr. Lynch has a non-compensated relationship as a Board Memeber of the mid-America Chapter with National MS Society that is relevant to AAN interests or activities. Dr. Lynch has a non-compensated relationship as a President of Board of Directors with Friends of MS Achievement Center that is relevant to AAN interests or activities.
No disclosure on file
No disclosure on file
David A. Hafler, MD, FAAN (Yale University School of Medicine, Dept of Neurology) Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech. Dr. Hafler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Hafler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Joint Commission International.
David Pitt, MD (Yale School of Medicine) Dr. Pitt has nothing to disclose.